Observational Copenhagen Pancreatic Cancer Study

Conditions: Pancreatic Cancer

Sex: All

Healthy volunteers: No

Enrollment: 8000

Sponsor: Inna Chen, MD

Location: Department of Oncology Herlev

Summary

The primary objective of the Copenhagen Pancreatic Cancer (COPAN) study is to describe the real-world population of patients with pancreatic cancer (PC). Larger sample of longitudinal real-world data provides a unique opportunity for comprehensive exploration of the diagnostic and treatment journey for individuals diagnosed with PC and allows to investigate treatment outcomes and associated prognostic factors. Furthermore, the study aims to identify determinants of treatment management and treatment outcomes, including patient-reported outcomes.

Eligibility Criteria

Inclusion Criteria: Histologically confirmed pancreatic cancer Exclusion Criteria: * None

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06713525). StuddyBuddy aggregates publicly available trial information.